Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05869227
What this trial is testing

Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaMaintenance Therapy
XIANG YANQUN 166
Early research (Phase 1)Study completedNCT00078494
What this trial is testing

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
National Institutes of Health Clinical Center (CC) 99
Large-scale testing (Phase 3)Looking for participantsNCT04136886
What this trial is testing

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 346
Testing effectiveness (Phase 2)Looking for participantsNCT07528183
What this trial is testing

Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Study completedNCT04562441
What this trial is testing

NPC - AXEL Study : Axitinib-Avelumab

Who this might be right for
Recurrent or Metastatic NPC
Chinese University of Hong Kong 13
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)UnknownNCT05198531
What this trial is testing

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent / Metastatic Nasopharyngeal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00006248
What this trial is testing

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)UnknownNCT03854838
What this trial is testing

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsNasopharyngeal Diseases+1 more
Sun Yat-sen University 25
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Early research (Phase 1)UnknownNCT05222009
What this trial is testing

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Granulocyte Colony-Stimulating FactorPD-1 Inhibitor
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07331428
What this trial is testing

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

Who this might be right for
Nasopharyngeal CarcinomaLocal Recurrence
Fujian Cancer Hospital 25
Early research (Phase 1)UnknownNCT03282617
What this trial is testing

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 55
Early research (Phase 1)UnknownNCT02761291
What this trial is testing

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT02789189
What this trial is testing

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail

Who this might be right for
Recurrent and Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)UnknownNCT00003327
What this trial is testing

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Theradex 60
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Not applicableStudy completedNCT00899769
What this trial is testing

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 100
Next Page
40